259 related articles for article (PubMed ID: 10799884)
1. Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice.
Karachunski PI; Ostlie NS; Monfardini C; Conti-Fine BM
J Immunol; 2000 May; 164(10):5236-44. PubMed ID: 10799884
[TBL] [Abstract][Full Text] [Related]
2. Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis.
Ostlie NS; Karachunski PI; Wang W; Monfardini C; Kronenberg M; Conti-Fine BM
J Immunol; 2001 Apr; 166(8):4853-62. PubMed ID: 11290761
[TBL] [Abstract][Full Text] [Related]
3. C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells.
Wang W; Milani M; Ostlie N; Okita D; Agarwal RK; Caspi RR; Conti-Fine BM
J Immunol; 2007 Jun; 178(11):7072-80. PubMed ID: 17513756
[TBL] [Abstract][Full Text] [Related]
4. The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells.
Wang W; Ostlie NS; Conti-Fine BM; Milani M
J Immunol; 2004 Jan; 172(1):97-103. PubMed ID: 14688314
[TBL] [Abstract][Full Text] [Related]
5. Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice.
Ostlie N; Milani M; Wang W; Okita D; Conti-Fine BM
J Immunol; 2003 Jan; 170(1):604-12. PubMed ID: 12496449
[TBL] [Abstract][Full Text] [Related]
6. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis.
Balasa B; Deng C; Lee J; Christadoss P; Sarvetnick N
J Immunol; 1998 Sep; 161(6):2856-62. PubMed ID: 9743346
[TBL] [Abstract][Full Text] [Related]
7. Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences.
Karachunski PI; Ostlie NS; Okita DK; Conti-Fine BM
J Clin Invest; 1997 Dec; 100(12):3027-35. PubMed ID: 9399949
[TBL] [Abstract][Full Text] [Related]
8. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.
Balasa B; Deng C; Lee J; Bradley LM; Dalton DK; Christadoss P; Sarvetnick N
J Exp Med; 1997 Aug; 186(3):385-91. PubMed ID: 9236190
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4+ epitope sequences of the acetylcholine receptor.
Karachunski PI; Ostlie NS; Okita DK; Conti-Fine BM
J Neuroimmunol; 1999 Mar; 95(1-2):73-84. PubMed ID: 10229117
[TBL] [Abstract][Full Text] [Related]
10. Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production.
Deng C; Goluszko E; Tüzün E; Yang H; Christadoss P
J Immunol; 2002 Jul; 169(2):1077-83. PubMed ID: 12097416
[TBL] [Abstract][Full Text] [Related]
11. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
Zhang GX; Xiao BG; Bai XF; van der Meide PH; Orn A; Link H
J Immunol; 1999 Apr; 162(7):3775-81. PubMed ID: 10201893
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms by which the I-ABM12 mutation influences susceptibility to experimental myasthenia gravis: a study in homozygous and heterozygous mice.
Karachunski PI; Ostlie N; Bellone M; Infante AJ; Conti-Fine BM
Scand J Immunol; 1995 Aug; 42(2):215-25. PubMed ID: 7631155
[TBL] [Abstract][Full Text] [Related]
13. IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis.
Schaffert H; Pelz A; Saxena A; Losen M; Meisel A; Thiel A; Kohler S
Eur J Immunol; 2015 May; 45(5):1339-47. PubMed ID: 25676041
[TBL] [Abstract][Full Text] [Related]
14. IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease.
Moiola L; Galbiati F; Martino G; Amadio S; Brambilla E; Comi G; Vincent A; Grimaldi LM; Adorini L
Eur J Immunol; 1998 Aug; 28(8):2487-97. PubMed ID: 9710226
[TBL] [Abstract][Full Text] [Related]
15. Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats.
Saoudi A; Bernard I; Hoedemaekers A; Cautain B; Martinez K; Druet P; De Baets M; Guéry JC
J Immunol; 1999 Jun; 162(12):7189-97. PubMed ID: 10358165
[TBL] [Abstract][Full Text] [Related]
16. Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis.
Zhang GX; Xiao BG; Bakhiet M; van der Meide P; Wigzell H; Link H; Olsson T
J Exp Med; 1996 Aug; 184(2):349-56. PubMed ID: 8760788
[TBL] [Abstract][Full Text] [Related]
17. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells.
Akhiani AA; Pappo J; Kabok Z; Schön K; Gao W; Franzén LE; Lycke N
J Immunol; 2002 Dec; 169(12):6977-84. PubMed ID: 12471132
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: identification of regulatory cells.
Shi FD; Li H; Wang H; Bai X; van der Meide PH; Link H; Ljunggren HG
J Immunol; 1999 May; 162(10):5757-63. PubMed ID: 10229808
[TBL] [Abstract][Full Text] [Related]
19. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
[TBL] [Abstract][Full Text] [Related]
20. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.
Deng C; Goluszko E; Christadoss P
J Immunol; 2001 Mar; 166(5):3458-67. PubMed ID: 11207304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
